These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18990007)

  • 1. Why do men refuse prostate cancer screening? Demographic analysis in Turkey.
    Ceber E; Cakir D; Ogce F; Simsir A; Cal C; Ozentürk G
    Asian Pac J Cancer Prev; 2008; 9(3):387-90. PubMed ID: 18990007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Educating men about prostate cancer in the workplace.
    Ilic D
    Am J Mens Health; 2013 Jul; 7(4):285-94. PubMed ID: 23154199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do men refuse or attend population-based screening for prostate cancer?
    Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
    J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with organized and opportunistic cancer screening: Results of the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2011.
    Kang M; Yoo KB; Park EC; Kwon K; Kim G; Kim DR; Kwon JA
    Asian Pac J Cancer Prev; 2014; 15(7):3279-86. PubMed ID: 24815483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer awareness and screening practice among Kenyan men.
    Erena AN; Shen G; Lei P
    Eur J Cancer Prev; 2020 May; 29(3):252-258. PubMed ID: 32243332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.
    Braga R; Costa AR; Pina F; Moura-Ferreira P; Lunet N
    Eur J Cancer Prev; 2020 May; 29(3):248-251. PubMed ID: 31651568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening practice and knowledge in Rhode Island.
    Glicksman AS; Meyer A; Cullinen K
    Med Health R I; 2009 Feb; 92(2):65-6. PubMed ID: 19288690
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-reported reasons men decide not to participate in free prostate cancer screening.
    Weinrich SP; Weinrich MC; Priest J; Fodi C
    Oncol Nurs Forum; 2003; 30(1):E12-6. PubMed ID: 12515993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
    McDavid K; Melnik TA; Derderian H
    Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
    Tourville EA; Nguyen MM
    Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening for men aged 75 to 84 years in New South Wales.
    Carmichael LK; Goldsbury DE; O'Connell DL
    Aust N Z J Public Health; 2013 Oct; 37(5):492-4. PubMed ID: 24090337
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring prostate cancer screening among men in Accra using the health belief model.
    Boafo IM; Tetteh PM; Hiadzi RA
    Ghana Med J; 2023 Sep; 57(3):226-233. PubMed ID: 38957671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men.
    Rogers CR; Rovito MJ; Hussein M; Obidike OJ; Pratt R; Alexander M; Berge JM; Dall'Era M; Nix JW; Warlick C
    Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S103-S111. PubMed ID: 30670195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.